Cargando…

Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer

Although hormone therapy is effective for the treatment of prostate cancer (Pca), many patients develop a lethal type of Pca called castration-resistant prostate cancer (CRPC). Dysregulation of DNA damage response (DDR)-related genes leads to Pca progression. Here, we explored DDR-related signals up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oshima, Masashi, Takayama, Ken-ichi, Yamada, Yuta, Kimura, Naoki, Kume, Haruki, Fujimura, Tetsuya, Inoue, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638319/ https://www.ncbi.nlm.nih.gov/pubmed/37950047 http://dx.doi.org/10.1038/s41598-023-46651-6

Ejemplares similares

Ribonuclease H2 Subunit A Preserves Genomic Integrity and Promotes Prostate Cancer Progression
por: Kimura, Naoki, et al.
Publicado: (2022)

Androgen‐responsive tripartite motif 36 enhances tumor‐suppressive effect by regulating apoptosis‐related pathway in prostate cancer
por: Kimura, Naoki, et al.
Publicado: (2018)

TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma
por: Yamada, Yuta, et al.
Publicado: (2020)

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
por: Fujimura, Tetsuya, et al.
Publicado: (2015)

Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors
por: Takayama, Ken-ichi, et al.
Publicado: (2020)

The ‘prostate-muscle index’: a simple pelvic cavity measurement predicting estimated blood loss and console time in robot-assisted radical prostatectomy
por: Kimura, Naoki, et al.
Publicado: (2022)

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy
por: Takeshima, Yuta, et al.
Publicado: (2021)

The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy
por: Takeshima, Yuta, et al.
Publicado: (2022)

Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer
por: Hakozaki, Yuji, et al.
Publicado: (2022)

Androgen‐induced lncRNA POTEF‐AS1 regulates apoptosis‐related pathway to facilitate cell survival in prostate cancer cells
por: Misawa, Aya, et al.
Publicado: (2017)

Identification of new octamer transcription factor 1‐target genes upregulated in castration‐resistant prostate cancer
por: Yamamoto, Shinichiro, et al.
Publicado: (2019)

Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor
por: Yamada, Yuta, et al.
Publicado: (2016)

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients
por: Hakozaki, Yuji, et al.
Publicado: (2023)

Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer
por: Takayama, Ken-ichi, et al.
Publicado: (2021)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2020)

Left testicular and pulmonary metastases of mucinous adenocarcinoma of the prostate after robot‐assisted radical prostatectomy
por: Kato, Kisumi, et al.
Publicado: (2023)

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer
por: Takayama, Ken-ichi, et al.
Publicado: (2014)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

Clinical significance and risk factors of urethrovesical anastomotic urinary leakage following robot-assisted radical prostatectomy: a multi-institutional study
por: Kakutani, Shigenori, et al.
Publicado: (2021)

Long non‐coding RNAs and prostate cancer
por: Misawa, Aya, et al.
Publicado: (2017)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2020)

Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
por: Takayama, Ken-ichi, et al.
Publicado: (2017)

A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor
por: Yamada, Yuta, et al.
Publicado: (2016)

Castration-resistant prostate cancer with metastasis to external auditory canal – Case report
por: Akagi, Naoki, et al.
Publicado: (2022)

Castration‐resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy
por: Yanase, Atsuhi, et al.
Publicado: (2022)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
por: Oshima, Masashi, et al.
Publicado: (2019)

Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report
por: Mukaiyama, Yoshihiro, et al.
Publicado: (2014)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
por: Sumiyoshi, Takayuki, et al.
Publicado: (2019)

Clinical Significance of Amyloid Precursor Protein in Patients with Testicular Germ Cell Tumor
por: Yamada, Yuta, et al.
Publicado: (2013)

CLDN8, an androgen‐regulated gene, promotes prostate cancer cell proliferation and migration
por: Ashikari, Daisaku, et al.
Publicado: (2017)

Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality
por: Taguchi, Satoru, et al.
Publicado: (2015)

Surgical Tolerability and Frailty in Elderly Patients Undergoing Robot-Assisted Radical Prostatectomy: A Narrative Review
por: Yamada, Yuta, et al.
Publicado: (2022)

Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2017)

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
por: Francini, Edoardo, et al.
Publicado: (2021)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers
por: Takayama, Ken-ichi, et al.
Publicado: (2022)

Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death
por: Reddy, Vidyavathi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_evrrs1dcj4m6j68fke6t4seioo